HealthDay

Parkinson’s, osteoarthritis, rheumatic disease, heavy alcoholism linked to increased risk for readmission

Strongest associations seen in women younger than 60, those with systolic blood pressure below 120

Requiring impairment on two memory tests improves prediction of brain atrophy and progression to AD

16,100 CVD deaths attributable to higher sodium intake among those aged 25 to 69 in 2011

More attacks, higher odds of gadolinium-enhancing lesions for food allergy versus no known allergy

No increased risk observed for congenital malformations; small increased risk seen for oral clefts

No difference in cardiovascular disease, cancer, hip fracture for users or nonusers of vaginal estrogen

More greenness near residence linked to lower urinary levels of epinephrine and F2-isoprostane

Significant improvements seen in executive functioning for those at risk for cognitive decline

Disease-free, overall survival significantly longer compared with gemcitabine, but more adverse events

In 2018, the National Institutes of Health was funded approximately $115 million for research of the disease

Federal government urged to make naloxone more widely available, easier to obtain, and cheaper

Findings seen among rheumatoid arthritis patients on long-term biological therapy

Proportion of patients with uncontrolled blood pressure varies by health system and clinical site

Micronutrient supplements may be warranted for specific nutritional needs or deficiencies

Factors may ID older men and women at short- and long-term risk for injurious falls

Fraud, health crimes, substance abuse exclusions increased 20 percent per year from 2007 to 2017

New MRI technique to monitor liver fat shows normalization after a mean of 22.5 weeks

Guideline-directed medical therapy, lifestyle and risk factor modification are cornerstones of therapy

Report provides guidance for clinicians caring for children and youth with special health care needs